How AI Helps Scientists Create Next-Generation Drugs

AI accelerates the development of biological drugs, shortening timelines that used to span a decade. AstraZeneca uses machine learning to screen candidates, automate experiments, and build a "laboratory of the future." The company is moving toward fully AI-generated protein sequences (de novo design) with safety prediction through virtual clinical trials.

AstraZeneca